UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

Kidney international, 2014-03, Vol.85 (3), p.522-528

2014

Volltextzugriff (PDF)

Development of a microphysiological model of human kidney proximal tubule function

Kidney international, 2016-09, Vol.90 (3), p.627-637

2016

Volltextzugriff (PDF)

Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial

American journal of kidney diseases, 2017-03, Vol.69 (3), p.389-399

2017

Volltextzugriff (PDF)

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Frontiers in pharmacology, 2021-07, Vol.12

2021

Volltextzugriff (PDF)

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients

PloS one, 2016-08, Vol.11 (8), p.e0161074-e0161074

2016

Volltextzugriff (PDF)

Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system

Scientific reports, 2021-11, Vol.11 (1), p.21356-21356, Article 21356

2021

Volltextzugriff (PDF)

Predicting complex kidney drug handling using a physiologically‐based pharmacokinetic model informed by biomarker‐estimated secretory clearance and blood flow

Clinical and translational science, 2024-01, Vol.17 (1), p.e13678-n/a

2024

Volltextzugriff (PDF)

Tissue Chips in Space—Challenges and Opportunities

Clinical and translational science, 2020-01, Vol.13 (1), p.8-10

2020

Volltextzugriff (PDF)

Microphysiological systems in absorption, distribution, metabolism, and elimination sciences

Clinical and translational science, 2022-01, Vol.15 (1), p.9-42

2022

Volltextzugriff (PDF)

A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine[S]

Journal of lipid research, 2019-04, Vol.60 (4), p.892-899

2019

Volltextzugriff (PDF)

Development of a kidney microphysiological system hardware platform for microgravity studies

NPJ microgravity, 2024-05, Vol.10 (1), p.54-54, Article 54

2024

Volltextzugriff (PDF)

Modeling cellular responses to serum and vitamin D in microgravity using a human kidney microphysiological system

NPJ microgravity, 2024-07, Vol.10 (1), p.75-14, Article 75

2024

Volltextzugriff (PDF)

Kidneys on Chips: Emerging Technology for Preclinical Drug Development

Clinical journal of the American Society of Nephrology, 2019-01, Vol.14 (1), p.144-146

2019

Volltextzugriff (PDF)

Rapid and sensitive analysis of reduced and oxidized coenzyme Q10 in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and application to studies in healthy human subjects

Annals of clinical biochemistry, 2016-03, Vol.53 (2), p.265-273

2016

Volltextzugriff (PDF)

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression

Pediatric research, 2002-02, Vol.51 (2), p.236-243

2002

Volltextzugriff (PDF)

“Natural” is not synonymous with “Safe”: Toxicity of natural products alone and in combination with pharmaceutical agents

Regulatory toxicology and pharmacology, 2020-06, Vol.113, p.104642-104642, Article 104642

2020

Volltextzugriff (PDF)

Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury

Journal of the American Society of Nephrology, 2022-05, Vol.33 (5), p.949-965

2022

Volltextzugriff (PDF)

Analysis of Drug-Drug Interaction Labeling Language and Clinical Recommendations for Newly Approved Drugs Evaluated With Digoxin, Midazolam, and S-Warfarin

Clinical therapeutics, 2021-11, Vol.43 (11), p.2032-2039

2021

Volltextzugriff (PDF)

Microphysiological system modeling of ochratoxin A-associated nephrotoxicity

Toxicology (Amsterdam), 2020-11, Vol.444, p.152582-152582, Article 152582

2020

Volltextzugriff (PDF)

Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease

Pharmaceutical research, 2023-11, Vol.40 (11), p.2597-2606

2023

Volltextzugriff (PDF)

Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate

Journal of the American Society of Nephrology, 2021-02, Vol.32 (2), p.459-468

2021

Volltextzugriff (PDF)

Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver

The Journal of pharmacology and experimental therapeutics, 2017-11, Vol.363 (2), p.265-274

2017

Volltextzugriff (PDF)

Direct protein–protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1

FEBS letters, 2016-08, Vol.590 (16), p.2527-2535

2016

Volltextzugriff (PDF)

Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity

JCI insight, 2017-11, Vol.2 (22)

2017

Volltextzugriff (PDF)

Kidney microphysiological models for nephrotoxicity assessment

Current opinion in toxicology, 2022-06, Vol.30, p.100341, Article 100341

2022

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

Development of a microphysiological model of human kidney proximal tubule function

Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients

Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system

Predicting complex kidney drug handling using a physiologically‐based pharmacokinetic model informed by biomarker‐estimated secretory clearance and blood flow

Tissue Chips in Space—Challenges and Opportunities

Microphysiological systems in absorption, distribution, metabolism, and elimination sciences

A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine[S]

Development of a kidney microphysiological system hardware platform for microgravity studies

Modeling cellular responses to serum and vitamin D in microgravity using a human kidney microphysiological system

Kidneys on Chips: Emerging Technology for Preclinical Drug Development

Rapid and sensitive analysis of reduced and oxidized coenzyme Q10 in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and application to studies in healthy human subjects

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression

“Natural” is not synonymous with “Safe”: Toxicity of natural products alone and in combination with pharmaceutical agents

Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury

Analysis of Drug-Drug Interaction Labeling Language and Clinical Recommendations for Newly Approved Drugs Evaluated With Digoxin, Midazolam, and S-Warfarin

Microphysiological system modeling of ochratoxin A-associated nephrotoxicity

Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease

Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate

Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver

Direct protein–protein interactions and substrate channeling between cellular retinoic acid binding proteins and CYP26B1

Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity

Kidney microphysiological models for nephrotoxicity assessment

Suchergebnisse filtern